Virtu Financial’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Virtu Financial’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-25,455	Closed	-$22K	–	2270
2022 Q1	$22K	Buy	+25,455	New	+$32.3K	﹤0.01%	1288

Other funds holding ROIVW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial's ROIVW Position: Q2 2022 in Review

Virtu Financial sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q2 2022, closing a stake of 25,455 shares — an estimated $22K sold.

Virtu Financial first reported a position in ROIVW in Q1 2022 and held it in 1 quarter. The position peaked at $22K in Q1 2022. 31 funds tracked by Wall St. Rank hold ROIVW as of Q2 2022.

Virtu Financial reported no remaining Roivant Sciences Ltd. Warrant position as of Q2 2022 after selling out during the quarter.
Virtu Financial sold 25,455 Roivant Sciences Ltd. Warrant shares in Q2 2022, an estimated $22K.
Virtu Financial first reported a position in Roivant Sciences Ltd. Warrant in Q1 2022 and held it in 1 quarter.
Virtu Financial's Roivant Sciences Ltd. Warrant position peaked at $22K in Q1 2022.
31 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q2 2022.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.